A fascinating paper from Gradinaru et al describes a genetically engineered mouse model of Parkinson's disease that expresses a photoreceptor in the neurons of a particular part of the brain - the subthalamic nucleus (STN). This area is widely thought to be the central target of the immensely therapeutic technique for Parkinson's known as deep brain stimulation.